FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to (S)-(-)-amlodipine camsylate of formula 
, where camphorsulfonic acid represents (1S)-(+)-10- camphorsulfonic acid or (±)-10- camphorsulfonic acid, as well as to its hydrate and to pharmaceutical composition, including them, which can be applied in treatment of cardiovascular diseases.
EFFECT: high photostability and solubility.
8 cl, 3 ex, 5 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AMLODIPINE CAMSYLATE, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2241701C1 |
| S-OMEPRAZOLE STRONTIUM SALT OR HYDRATE THEREOF, METHOD OF PREPARING SAID COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS | 2006 |
|
RU2372345C1 |
| METHOD FOR PRODUCTION OF AMLODIPINE ENANTIOMER OF HIGH OPTIC PURITY | 2005 |
|
RU2376288C2 |
| AMLODIPINE GENTISATE AND ITS OBTAINING METHOD | 2004 |
|
RU2330843C2 |
| METHOD OF PREPARING CHIRAL AMLODIPINE GENTISATE | 2006 |
|
RU2393150C2 |
| COMPLEX PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE, LOSARTAN AND CHLORTHALIDONE | 2016 |
|
RU2713883C2 |
| PHARMACEUTICAL COMPOSITION INCLUDING CRYSTALLINE SIBUTRAMINE METHANESULFONATE HEMIHYDRATE | 2003 |
|
RU2290924C2 |
| HYDRATES OF ERYTHROMYCIN SALTS, THEIR OBTAINING AND APPLICATION | 2009 |
|
RU2510659C2 |
| CRYSTAL FORM OF PHOSPHODIESTERASE INHIBITOR, METHOD OF ITS PREPARATION AND USE | 2020 |
|
RU2814498C2 |
| COMPOSITION INCLUDING AMLODIPINE AND LOSARTAN HAVING IMPROVED STABILITY | 2013 |
|
RU2628538C2 |
